We are a single-family investment office practicing value investing through growth and longevity. Headquartered in Singapore, we are an extension to one of Southeast Asia's premier conglomerates. Our investing ethos is to preserve and grow our undertakings in a responsible and disciplined manner, safeguarding principles which have been successfully inculcated by our founder when the business was starting out as a small unit in the early 1900's. Our focus and strength lie in building ecosystems, applying long-term investment methodology across selected public and private markets globally, while also achieving outstanding results and returns on projects we have and are currently involved in.
We came from humble beginnings where our founding father started with very little, having a small sundry shop but harboring a grand vision. Today, our parent conglomerate operates in a number of business verticals globally, in sectors covering Healthcare, Natural Resources, Consumer, Technology, Chemicals, Paper and Pulp to name a few, providing proof of our founding father's vision, backed by a resilient heritage of operating excellence and the highest of standards. This legacy shapes our approach in investing, guiding us with our legacy ethos crafted over many years.
We invest long term, focusing our efforts on high-quality enterprises with a strong sustainable growth story. We aim to achieve attractive returns through our investment ethos, with the conviction that the correct application and deployment of capital will stand the test of time and stay resilient across generations.
We pursue control buyouts where deployable capital, strong operating heritage, and the willingness and ability to hold longer term translate directly into strong compounding value.
We are anchored in Southeast Asia, offering us access and proximity in our application and attentiveness across the region. Our far-reaching operating capabilities also let us tap into a wide selection of global market opportunities, allowing for exclusivity and development.
GAC strategically allocates capital across resilient and high-growth sectors, maintaining a disciplined investment mandate anchored by the safeguarding of generational wealth
A growth strategy focused on scaling transformative medical technologies. GAC provides the capital and operational expertise to expand global reach and generate positive outcomes across the healthcare value chain.
Investing in the next generation of aerospace, autonomous systems, and deep-tech technology that push the boundaries of modern engineering and technical capability
Investing in the physical foundations of excellence across academic institution and learning centers. We prioritize the development of infrastructure that serves the entire educational lifecycle.
